<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28871120</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Development of a luciferase-based biosensor to assess enterovirus 71 3C protease activity in living cells.</ArticleTitle><Pagination><StartPage>10385</StartPage><MedlinePgn>10385</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">10385</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-017-10840-x</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is a major pathogen of hand, foot, and mouth disease&#xa0;(HFMD). To date, no antiviral drug has been approved to treat EV71 infection. Due to the essential role that EV71 3&#x2009;C protease (3C<sup>pro</sup>) plays in the viral life cycle, it is generally considered as a highly appealing target for antiviral drug development. In this study, we present a transgene-encoded biosensor that can accurately, sensitively and quantitatively report the proteolytic activity of EV71 3C<sup>pro</sup>. This biosensor is based on the catalyzed activity of a pro-interleukin (IL)-1&#x3b2;-enterovirus 3C<sup>pro</sup> cleavage site-Gaussia Luciferase (GLuc) fusion protein that we named i-3CS-GLuc. GLuc enzyme is inactive in the fusion protein because of aggregation caused by pro-IL-1&#x3b2;. However, the 3C<sup>pro</sup> of EV71 and other enteroviruses, such as coxsackievirus A9 (CVA9), coxsackievirus B3 (CVB3), and poliovirus can recognize and process the canonical enterovirus 3C<sup>pro</sup> cleavage site between pro-IL-1&#x3b2; and GLuc, thereby releasing and activating GLuc and resulting in increased luciferase activity. The high sensitivity, ease of use, and applicability as a transgene in cell-based assays of i-3CS-GLuc biosensor make it a powerful tool for studying viral protease proteolytic events in living cells and for achieving high-throughput screening of antiviral agents.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ke</LastName><ForeName>Xianliang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Guangzhou Institute of Pediatrics, Guangzhou Women and Children Medical Center, Guangzhou, 510623, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Caishang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Guangzhou Institute of Pediatrics, Guangzhou Women and Children Medical Center, Guangzhou, 510623, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Zhenhua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hanzhong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Key Laboratory of Special Pathogens and Biosafety, Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China. wanghz@wh.iov.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015374" MajorTopicYN="N">Biosensing Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28871120</ArticleId><ArticleId IdType="pmc">PMC5583365</ArticleId><ArticleId IdType="doi">10.1038/s41598-017-10840-x</ArticleId><ArticleId IdType="pii">10.1038/s41598-017-10840-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen CY, et al. Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates. American Journal of Neuroradiology. 2001;22:200&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7975539</ArticleId><ArticleId IdType="pubmed">11158910</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee TC, et al. Diseases Caused by Enterovirus 71 Infection. Pediatric Infectious Disease Journal. 2009;28:904&#x2013;910. doi: 10.1097/INF.0b013e3181a41d63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e3181a41d63</ArticleId><ArticleId IdType="pubmed">20118685</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129:304&#x2013;9. doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Stratov I, Nagarajan L, Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clinical Infectious Diseases. 2001;32:236&#x2013;242. doi: 10.1086/318454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318454</ArticleId><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>AbuBakar S, et al. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Research. 1999;61:1&#x2013;9. doi: 10.1016/S0168-1702(99)00019-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-1702(99)00019-2</ArticleId><ArticleId IdType="pubmed">10426204</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander JP, Baden L, Pallansch MA, Anderson LJ. Enterovirus-71 Infections and Neurologic Disease - United-States, 1977&#x2013;1991. Journal of Infectious Diseases. 1994;169:905&#x2013;908. doi: 10.1093/infdis/169.4.905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/169.4.905</ArticleId><ArticleId IdType="pubmed">8133108</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehle J, Roth B, Metzger C, Pfitzner A, Enders G. Molecular characterization of an Enterovirus 71 causing neurological disease in Germany. Journal of Neurovirology. 2003;9:126&#x2013;128. doi: 10.1080/13550280390173364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280390173364</ArticleId><ArticleId IdType="pubmed">12587076</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho MT, et al. An epidemic of enterovirus 71 infection in Taiwan. New England Journal of Medicine. 1999;341:929&#x2013;935. doi: 10.1056/NEJM199909233411301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J. 2010;7 doi: 10.1186/1743-422X-7-94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-94</ArticleId><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Li RC, et al. An Inactivated Enterovirus 71 Vaccine in Healthy Children. New England Journal of Medicine. 2014;370:829&#x2013;837. doi: 10.1056/NEJMoa1303224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Jin Q, He YQ, Li LC, Hou YD. The complete genome of Enterovirus 71 China strain. Science in China Series C-Life Sciences. 2001;44:178&#x2013;183. doi: 10.1007/BF02879323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02879323</ArticleId><ArticleId IdType="pubmed">18726435</ArticleId></ArticleIdList></Reference><Reference><Citation>De Palma AM, et al. Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307. Antimicrob Agents Chemother. 2009;53:1850&#x2013;7. doi: 10.1128/AAC.00934-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00934-08</ArticleId><ArticleId IdType="pmc">PMC2681499</ArticleId><ArticleId IdType="pubmed">19237651</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. Fems Microbiology Reviews. 2002;26:91&#x2013;107. doi: 10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ML, et al. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology. 2002;293:386&#x2013;395. doi: 10.1006/viro.2001.1310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1310</ArticleId><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, et al. Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its RNA binding and proteolytic activities. Journal of Biomedical Science. 2004;11:239&#x2013;248. doi: 10.1007/BF02256567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02256567</ArticleId><ArticleId IdType="pubmed">14966374</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewet JR, Wood KV, Helinski DR, Deluca M. Cloning of Firefly Luciferase Cdna and the Expression of Active Luciferase in Escherichia-Coli. Proceedings of the National Academy of Sciences of the United States of America. 1985;82:7870&#x2013;7873. doi: 10.1073/pnas.82.23.7870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.82.23.7870</ArticleId><ArticleId IdType="pmc">PMC390871</ArticleId><ArticleId IdType="pubmed">3906652</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews JC, Hori K, Cormier MJ. Purification and Properties of Renilla-Reniformis Luciferase. Biochemistry. 1977;16:85&#x2013;91. doi: 10.1021/bi00620a014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00620a014</ArticleId><ArticleId IdType="pubmed">12797</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams TM, Burlein JE, Ogden S, Kricka LJ, Kant JA. Advantages of Firefly Luciferase as a Reporter Gene - Application to the Interleukin-2 Gene Promoter. Analytical Biochemistry. 1989;176:28&#x2013;32. doi: 10.1016/0003-2697(89)90267-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-2697(89)90267-4</ArticleId><ArticleId IdType="pubmed">2785354</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowlby MR, Case JF. Flash Kinetics and Spatial Patterns of Bioluminescence in the Copepod Gaussia-Princeps. Marine Biology. 1991;110:329&#x2013;336. doi: 10.1007/BF01344351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01344351</ArticleId></ArticleIdList></Reference><Reference><Citation>Ketteler, R., Sun, Z. R., Kovacs, K. F., He, W. W. &amp; Seed, B. A pathway sensor for genome-wide screens of intracellular proteolytic cleavage. Genome Biology9 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2643935</ArticleId><ArticleId IdType="pubmed">18387192</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartok E, et al. iGLuc: a luciferase-based inflammasome and protease activity reporter. Nature Methods. 2013;10:147&#x2013;154. doi: 10.1038/nmeth.2327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2327</ArticleId><ArticleId IdType="pmc">PMC4127477</ArticleId><ArticleId IdType="pubmed">23291722</ArticleId></ArticleIdList></Reference><Reference><Citation>Jethra G, Mishra AK, Pandey PS, Chandrasekharan H. Structure and function prediction of unknown wheat protein using LOMETS and I-TASSER. Indian Journal of Agricultural Sciences. 2012;82:867&#x2013;874.</Citation></Reference><Reference><Citation>Roy A, Kucukural A, Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nature Protocols. 2010;5:725&#x2013;738. doi: 10.1038/nprot.2010.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2010.5</ArticleId><ArticleId IdType="pmc">PMC2849174</ArticleId><ArticleId IdType="pubmed">20360767</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JY, et al. The I-TASSER Suite: protein structure and function prediction. Nature Methods. 2015;12:7&#x2013;8. doi: 10.1038/nmeth.3213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3213</ArticleId><ArticleId IdType="pmc">PMC4428668</ArticleId><ArticleId IdType="pubmed">25549265</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S, et al. Crystal structure of human enterovirus 71 3C protease. J Mol Biol. 2011;408:449&#x2013;61. doi: 10.1016/j.jmb.2011.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2011.03.007</ArticleId><ArticleId IdType="pmc">PMC7094522</ArticleId><ArticleId IdType="pubmed">21396941</ArticleId></ArticleIdList></Reference><Reference><Citation>Binford SL, et al. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. Antimicrob Agents Chemother. 2005;49:619&#x2013;26. doi: 10.1128/AAC.49.2.619-626.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.49.2.619-626.2005</ArticleId><ArticleId IdType="pmc">PMC547258</ArticleId><ArticleId IdType="pubmed">15673742</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XN, et al. Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: Evaluation of antiviral efficacy in a murine infection model. Antiviral Research. 2013;97:264&#x2013;269. doi: 10.1016/j.antiviral.2012.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.029</ArticleId><ArticleId IdType="pubmed">23295352</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JH, Chung TDY, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. Journal of Biomolecular Screening. 1999;4:67&#x2013;73. doi: 10.1177/108705719900400206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/108705719900400206</ArticleId><ArticleId IdType="pubmed">10838414</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Wakita T, Shimizu H. Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. Journal of General Virology. 2008;89:2518&#x2013;2530. doi: 10.1099/vir.0.2008/002915-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.2008/002915-0</ArticleId><ArticleId IdType="pubmed">18796721</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo ZW, et al. A 3C(pro)-dependent bioluminescence imaging assay for in vivo evaluation of anti-enterovirus 71 agents. Antiviral Research. 2014;101:82&#x2013;92. doi: 10.1016/j.antiviral.2013.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.11.002</ArticleId><ArticleId IdType="pubmed">24263113</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan NP, Harrison-Shostak DC, Michaux J, Herman B. Novel mutant green fluorescent protein protease substrates reveal the activation of specific caspases during apoptosis. Chemistry &amp; Biology. 1999;6:401&#x2013;409. doi: 10.1016/S1074-5521(99)80051-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-5521(99)80051-9</ArticleId><ArticleId IdType="pubmed">10375546</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamek RN, Maniquis RV, Khakoo S, Bridges MD, Salzameda NT. A FRET-based assay for the discovery of West Nile Virus NS2B-NS3 protease inhibitors. Bioorganic &amp; Medicinal Chemistry Letters. 2013;23:4848&#x2013;4850. doi: 10.1016/j.bmcl.2013.06.081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2013.06.081</ArticleId><ArticleId IdType="pubmed">23886689</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, et al. Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and Coronaviruses. Journal of Virology. 2012;86:11754&#x2013;11762. doi: 10.1128/JVI.01348-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01348-12</ArticleId><ArticleId IdType="pmc">PMC3486288</ArticleId><ArticleId IdType="pubmed">22915796</ArticleId></ArticleIdList></Reference><Reference><Citation>Tannous BA, Kim DE, Fernandez JL, Weissleder R, Breakefield XO. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Molecular Therapy. 2005;11:435&#x2013;443. doi: 10.1016/j.ymthe.2004.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2004.10.016</ArticleId><ArticleId IdType="pubmed">15727940</ArticleId></ArticleIdList></Reference><Reference><Citation>Venisnik KM, Olafsen T, Gambhir SS, Wu AM. Fusion of Gaussia luciferase to an engineered anti-carcinoembryonic antigen (CEA) antibody for in vivo optical imaging. Molecular Imaging and Biology. 2007;9:267&#x2013;277. doi: 10.1007/s11307-007-0101-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11307-007-0101-8</ArticleId><ArticleId IdType="pubmed">17577599</ArticleId></ArticleIdList></Reference><Reference><Citation>Wurdinger T, et al. A secreted luciferase for ex vivo monitoring of in vivo processes. Nature Methods. 2008;5:171&#x2013;173. doi: 10.1038/nmeth.1177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1177</ArticleId><ArticleId IdType="pmc">PMC2699561</ArticleId><ArticleId IdType="pubmed">18204457</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzi M. Sampling variation of the fifty percent end-point, determined by the Reed-Muench (Behrens) method. Hum Biol. 1950;22:151&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">14778593</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>